From Treating a Diagnosis to Treating the Patient

BostonGene’s mission is to power healthcare’s transition to personalized medicine using AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics.

The BostonGene Tumor Portrait™ test integrates genomic (WES) and transcriptomic (RNA-seq) analyses of tumors and the tumor microenvironment in the single report to reveal key drivers of each tumor, including:

  • Immune microenvironment properties
  • Actionable mutations
  • Biomarkers of response to diverse therapies
  • Therapy options

After a comprehensive analysis, the BostonGene Tumor Portrait™ test generates a personalized roadmap for therapeutic decision-making for individual cancer patients.

Contact us